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Background: The outcomes of acute kidney injury (AKI) are well appreciated. However, valid indicators of high
quality processes of care for AKI after major surgery are lacking.
Objectives: To identify indicators of high quality processes of care related to AKI prevention, identification, and
management after major surgery.
Design: A three stage modified Delphi process.
Setting: The study was conducted in Alberta, Canada using an online format.
Participants: A panel of care providers from surgery, critical care, and nephrology.
Measurements: The degree of validity of candidate indicators were rated by panelists on a 7-point Likert scale that
ranged from “strongly disagree” to “strongly agree”.
Methods: A focused literature review was performed to identify candidate indicators. A modified Delphi process, with
three rounds, was used to obtain expert consensus on the validity of potential process of care quality indicators.
Results: Thirty-three physicians participated (6 from surgery, 10 from critical care, and 17 from nephrology). A list of 58
potential process of care quality indicators for AKI after surgery was generated including 28 indicators from the initial
literature review and 30 indicators suggested by panelists. Following the third round of questioning, 40 process of care
indicators were identified with a high level of agreement for face validity; 16 of these reached high consensus among
all panelists.
Limitations: The consensus of panelists from Alberta, Canada may not be generalizable to other settings. The modified
Delphi process did not focus on the feasibility of measuring these process indicators.
Conclusions: These indicators can be used to measure and improve the quality of care for AKI after major surgery.
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Contexte: Les répercussions engendrées par l’insuffisance rénale aiguë (IRA) sont bien connues. Cependant, il
n’existe toujours pas d’indicateurs de la qualité du processus de soin de l’IRA valides en phase postopératoire.
Objectifs de l’Étude: Élaborer des indicateurs de la qualité des processus de soin en matière de prévention,
d’identification et de prise en charge de l’IRA en phase postopératoire d’une chirurgie majeure.
Type d’étude: Processus Delphi modifié à trois étapes.
Lieu de l’Étude: L’étude a été effectuée en Alberta, Canada, par l’intermédiaire de questionnaires en ligne.
Participants: Panel de professionnels de la santé des milieux suivants : chirurgie, soins intensifs et néphrologie.
Mesures: Les panelistes ont évalué le degré de validité des indicateurs potentiels avec une échelle de Likert à 7
éléments, dont l’étendue se situait entre « fortement en désaccord » (valeur originale : strongly disagree) et « fortement
en accord » (valeur originale : strongly agree).
Méthode: Une revue de la littérature ciblée a été effectuée pour faire ressortir les indicateurs pertinents. Une version
modifiée du processus Delphi, comprenant trois étapes, a été utilisée dans le but d’obtenir l’avis des experts sur la
validité des indicateurs potentiels en matière de qualité des processus de soin.
Résultats: Trente-trois médecins ont participé au panel (6 chirurgiens, 10 intensivistes et 17 néphrologues). Une liste de
58 indicateurs potentiels de la qualité des processus de soin pour l’IRA en période postopératoire a été élaborée; celle-ci
comprenait 28 indicateurs qui provenaient de la revue de la littérature et 30 qui avaient été suggérés par les panelistes.
Après la troisième ronde de questionnaires, 40 indicateurs des processus de soins avaient été retenus pour leur validité
apparente, avec un haut niveau d’accord parmi le panel, et 16 de ces indicateurs avaient atteint un fort consensus.
Limites de l’Étude: Le consensus qui provient du panel formé en Alberta, Canada, n’est peut-être pas généralisable à
d’autres contextes. Le processus Delphi modifié ne s’est pas penché sur la faisabilité de la mesure des indicateurs
de processus de soin.
Conclusion: Ces indicateurs peuvent être utilisés pour mesurer et améliorer la qualité des soins de l’IRA en
période postopératoire d’une chirurgie majeure.What was known before
Variability in processes of care for acute kidney injury
(AKI) is common. Identification of valid process of care in-
dicators is useful to assess the quality of care, so that it can
be measured, monitored, and targeted for improvement.
What this adds
This study identified 40 process of care quality indicators
with high perceived validity, including 16 that reached
high consensus among all expert panelists, for the preven-
tion, identification, and management of AKI after major
surgery. These indicators can be used to design and evalu-
ate initiatives to improve the care of patients with or at
risk of AKI after surgery.
Background
AKI is a common problem, with an incidence of 4-7%
among all hospital admissions [1-4] and 10-30% after
major surgery. AKI is associated with morbidity, in-
creased length of hospital stay, progression to end-stage
renal disease (ESRD), high healthcare costs, and death
[5-10]. The utilization of dialysis for AKI after major
surgery has increased more than 3-fold over the last
10 years in Canada, contributing to longer hospital stays
and higher costs of care [11].While the important outcomes of AKI have been broadly
recognized, a lack of consensus remains about high quality
processes of care that are important for prevention and
management of AKI [12,13]. Variability in processes of care
for AKI is reported to be common, despite calls for ini-
tiatives to improve the quality of care for patients with
or at high risk of AKI [14-16]. Identification of valid
process of care indicators for AKI after major surgery
would be useful to assess the quality of this care, so
that it can be measured, monitored and targeted for
improvement [17-20]. Several recently published clin-
ical practice guidelines provide recommendations for
AKI prevention, identification and treatment; however,
few aspects of AKI prevention and management have
been evaluated in rigorously conducted empirical studies
in the perioperative setting, and so quality indicators for
AKI prevention and care must be selected partly based on
the opinions and experience of clinicians with knowledge
in this area [21,22].
To inform the development of future initiatives to im-
prove care for AKI after major surgery, we undertook a
3-stage, modified Delphi process with care providers
from surgery, critical care, and nephrology in Alberta,
Canada. Our aim was to achieve consensus among ex-
perts about the most important processes of care for
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major surgery.
Methods
This modified process was performed according to a
pre-specified protocol and adhered to published recom-
mendations for reporting [23]. Approval of the study
was obtained from the Conjoint Health Research Ethics
Board of the University of Calgary.
Panel selection
A mixed-specialty panel of participants was selected
based on known clinical expertise in the areas of surgery,
critical care, and nephrology. All invited panelists were
physicians with experience caring for patients with or at
risk of AKI in Alberta. Participants were approached with
an introductory email including a letter of invitation out-
lining the method and reason their participation in the
whole process was important. A subpanel of 6 researchers,
including 3 with expertise in the Delphi technique,
was created to provide input to refine each round of
questioning.
Literature search
As an initial step, a focused literature search was per-
formed to identify guideline recommendations and po-
tential process of care indicators for the prevention,
identification, and general management of AKI after
major surgical and contrast imaging procedures. The lit-
erature search involved searches of Medline, EMBASE,
and the Cochrane library without date limits or language
restriction and was completed in the last week of April
2013. The literature search was based on search terms
related to three themes: AKI, clinical guidelines, and
quality indicators (Additional file 1). Grey literature was
also searched using the Google Search engine as well as
unpublished internet reports, guidelines, and society re-
ports on AKI management. Two reviewers examined the
identified literature, extracted pertinent guideline state-
ments from the search yield, and grouped the extracted
statements about process indicators according to the
relevant phase of AKI care (prevention, identification,
and management).
List of potential indicators
A list of potential process of care indicators was gener-
ated from the literature search. The initial list was modi-
fied by the 6 member subpanel to reduce redundancy by
combining common process indicators where possible
and limiting potential indicators to actionable items. For
the purposes of our work, guideline statements or po-
tential indicators focusing on delivery of renal replace-
ment therapy for AKI were excluded.Overview of modified Delphi process
Three rounds of questions were distributed via Internet-
based questionnaires to all participants between September
2013 and May 2014. Panelists provided consent to par-
ticipate in the entire modified Delphi process on an
online form distributed with the first round of ques-
tions. Reminder emails were sent to non-respondents
at two and four weeks after distribution of each round.
Panelists were given the option of using mailed ques-
tionnaires; however, all participants chose to respond
using the Internet.
Round 1
Panelists were emailed a user-unique link to a question-
naire developed using the online software FluidSurveys
(http://fluidsurveys.com). Panelists were first asked about
their number of years in clinical practice, their primary
specialty, and the number of patients with AKI they typic-
ally care for each year. The refined list of AKI clinical
process of care indicators developed from the literature
search was presented to panelists, grouped according to
statements for perioperative AKI prevention/monitoring,
contrast-induced AKI prevention, monitoring/manage-
ment of AKI, and specialist consultation for AKI. Panelists
were asked to respond to the validity of each statement
with “agree”, “disagree”, or “unsure”. Open-ended ques-
tions were also provided, asking panelists to list other clin-
ical processes of care that they felt were important for
each of these aspects of AKI. Panelists were also asked to
provide criteria that they felt should prompt a consult
with a specialist (critical care physicians or nephrologist)
for a patient with AKI.
Round 2
The second round of the survey was based on a refined
list of additional process of care indicators. The refined
list was developed from responses to the open-ended
questions collected in Round 1. Panelists were again
asked to respond to the validity of each candidate indica-
tor with “agree”, “disagree”, or “unsure”. No open-ended
questions were provided in this round.
Round 3
The third round of the survey included all process of care
indicators provided in Rounds 1 and Round 2. In this round,
the percentage of panelists that responded “agree” to each
candidate indicator in the previous rounds was provided.
Panelists were asked to respond to the degree of validity of
each candidate indicator using a 7-point Likert scale that
ranged from “strongly disagree” to “strongly agree”.
Analysis
Results were tabulated at the completion of each round
and entered into an Excel worksheet. The percentage
Systematic review of literature 
(n=117 articles identified) 
Full text review of articles
(n=33 articles selected)
Round 1
Potential process indicators provided to panelists 
(n=28 indicators)
Round 2
Additional potential indicators suggested by panelists 
(n=30 indicators)
Round 3
All potential indicators provided to panelists 
(n=58 indicators)
Final Indicators
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tion after Rounds 1 and 2 (Appendix 1). Following the
completion of Round 3, mean (95% confidence interval)
responses on the 7-point Likert scale were calculated for
each question. Candidate indicators with mean scores of
0–3 were categorized as of low perceived validity, 4–5 as
moderate perceived validity, and 6–7 as representing
high perceived validity. Process indicators with a mean
score greater than 6 were identified as having a high de-
gree of validity and included in a final list of valid indi-
cators. Those indicators for which no panelists assigned
a score less than six were identified as high consensus
indicators.
Results
A total of 51 clinicians were invited as potential panel-
ists, and 33 (64.70%) agreed to participate. The charac-
teristics of the panelists are shown in Table 1. There
were 6 panelists (18.2%) from surgery, 10 (30.3%) from
critical care, and 17 (51.5%) from nephrology. The range
of post-training clinical practice among panelists ranged
from less than 5 to more than 30 years. Most reported
that they cared for more than 60 patients with AKI each
year.
In total, 31 (97%) panelists who agreed to participate
responded to Round 1. Panelists provided responses to
28 process of care indicators identified from the literature
review, and provided open ended responses that resulted
in 30 additional potential process of care indicators for fur-
ther evaluation (Figure 1). In Round 2, 27 (82%) panelists
responded to the questionnaire. A summary of responsesTable 1 Characteristics of panelists (n = 33)
Number (%)







Primary Area of Specialty
Surgery 6 (18)
Nephrology 17 (52)
Critical Care 10 (30)






High validity (mean score>6) (n=40)
High consensus (all panelists scored >6) (n=16)
Figure 1 Progress through steps of the literature search and
modified Delphi procedure to identify process of care
indicators for the identification, prevention and management
of acute kidney injury after major surgery.to the full 58 process of care statements provided in
Rounds 1 and 2 of the Delphi process is provided in
brackets following the text statements in Figures 2-5.
In total, 30 (91%) panelists responded to the question-
naire in Round 3. Mean (95% confidence intervals) scores
for each of the process of care indicators are shown graph-
ically in Figures 2. Forty process of care indicators had a
mean score greater than 6, indicating high agreement for
validity (Table 2); 12 were for prevention and early
Identification of AKI after major surgery, 12 were for early
management of AKI after major surgery, 5 were for preven-
tion of contrast-induced AKI after major surgery, and 11
were criteria for nephrologist or critical care consultation in
AKI. Of these 40 process of care quality indicators with
high perceived validity, 22 (55%) were indicators originally
Figure 2 Perceived Validity of Candidate Process of Care Quality Indicators for Prevention and Early Identification of Acute Kidney
Injury after Major Surgery. The bars represent the mean scores with 95% confidence intervals. The number in brackets following each
indicator represents the percentage of participants that stated they agreed with the indicator in the initial round of questioning, and was
presented to participants in the final round. The horizontal line represents the median score for all indicators.
Figure 3 Perceived Validity of Candidate Process of Care Quality Indicators for Early Management of Acute Kidney Injury after Major
Surgery. The bars represent the mean scores with 95% confidence intervals. The number in brackets following each indicator represents the
percentage of participants that stated they agreed with the indicator in the initial round of questioning, and was presented to participants in the
final round. The horizontal line represents the median score for all indicators.
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Figure 4 Perceived Validity of Candidate Process of Care Quality Indicators for Prevention of Contrast-induced AKI. The bars represent
the mean scores with 95% confidence intervals. The number in brackets following each indicator represents the percentage of participants that
stated they agreed with the indicator in the initial round of questioning, and was presented to participants in the final round. The horizontal line
represents the median score for all indicators.
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indicators suggested by panelists. Of the 40 indicators, 16
(40%) were scored greater than 6 by all participants consist-
ent with the definition of high consensus indicators.
Discussion
Using a modified Delphi method involving a panel of
Alberta physician specialists, we identified 40 process of
care quality indicators with high perceived validity for the
prevention, identification, and management of AKI after
major surgery. Sixteen of these process indicators were
identified by panel members with high consensus.
The process of care quality indicators identified as having
high validity by our panelists demonstrate the perceived im-
portance of risk stratification and identification of patients
at high risk of AKI as well as clinical and laboratory moni-
toring for early identification of AKI. Our findings illustrate
high agreement for monitoring serum creatinine, urine out-
put, and fluid balance after major surgery, with the addition
of laboratory testing for, acidosis, and hyperkalemia follow-
ing AKI onset. Careful monitoring of these measures may
aid early recognition of AKI and, provide opportunities to
intervene before severe complications develop [6]. This is
consistent with recent guidelines for AKI that recommend
routine monitoring of patients at risk of AKI in order to
ensure timely recognition of AKI [21,24].With respect to early management of AKI post surgery,
indicators including use of intravenous crystalloids for
intravascular volume expansion, withholding non-steroidal
anti-inflammatory drugs (NSAIDs), aminoglycosides, and
withholding or avoiding diuretics in the absence of volume
overload, and reviewing current medications to identify
those that are nephrotoxic or require dose adjustment also
achieved high agreement by panelists. This is consistent with
research suggesting that these medications are modifiable
risk factors for AKI [6,7,21,24]. There was also general con-
sensus among panel members that several process of care
indicators for prevention of contrast-induced AKI were
important. These included indicators to avoid NSAIDs and
diuretics prior to contrast exposure and to minimize or
avoid the use of intravenous contrast when possible.
There was high agreement on four indicators of need
for critical care consultation when AKI was accompanied
by circulatory or respiratory failure. However, only one of
seven final indicators for nephrology consult reached
consensus. This may reflect varying perspectives about the
role nephrologists play in management of typical cases of
AKI due to pre-renal causes or acute tubular necrosis after
surgery [25-27].
These process of care quality indicators may be used in
future quality improvement or research studies of peri-
operative AKI. Researchers could use these indicators as
Figure 5 Perceived Validity of Candidate Process of Care Quality Indicators for Specialist Consultation for Acute Kidney Injury. The bars
represent the mean scores with 95% confidence intervals. The number in brackets following each indicator represents the percentage of participants
that stated they agreed with the indicator in the initial round of questioning, and was presented to participants in the final round. The horizontal line
represents the median score for all indicators.
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Table 2 Process of care quality indicators identified as having a high degree of validity in the prevention,
identification, and management of acute kidney injury (AKI) after major surgery*
Number (%) who scored
indicator ≥6/7†
Prevention and Early Identification of AKI after major surgery
Obtain a serum creatinine before surgery 30 (100)
Use isotonic crystalloids to expand intravascular volume during surgery 29 (97)
Monitor serum creatinine daily to identify AKI after surgery 26 (87)
Monitor urine output daily to identify AKI after surgery 29 (97)
Monitor fluid balance daily after surgery 26 (87)
In the absence of volume overload, provide maintenance IV fluids after surgery 30 (100)
Administer aminoglycosides using single daily dosing in patients at risk of AKI 25 (83)
Discontinue non-steroidal anti-inflammatory drugs prior to surgery 28 (93)
Avoid repeated exposure to iodinated contrast after surgery 26 (87)
Monitor serum creatinine after prescribing a nephrotoxic drug 29 (97)
Avoid hydroxy-ethyl starch for volume expansion in patients with reduced kidney function‡ 26 (87)
Flag patients at high risk of perioperative acute kidney injury in the medical record 28 (93)
Early Management of AKI After major surgery:
Perform a urinalysis for investigation of the cause of AKI 29 (97)
Determine the severity of AKI by monitoring serum creatinine daily after the onset of AKI 30 (100)
Determine the severity of AKI by monitoring urine output daily after the onset of AKI 30 (100)
Monitor fluid balance daily after the onset of AKI 30 (100)
Monitor for acid–base disturbances after the onset of AKI 29 (97)
Monitor for hyperkalemia after the onset of AKI 30 (100)
Provide intravenous crystalloids to optimize hemodynamic status and restore effective circulating volume and blood
pressure in patients with AKI and signs of volume depletion
30 (100)
Avoid non-steroidal anti-inflammatory drugs after the onset of AKI 30 (100)
Avoid aminoglycosides after the onset of AKI unless no other antibiotics are available 27 (90)
Provide vasopressors/inotropes to patients with AKI and vasomotor shock that does not respond to IV fluids 29 (97)
Review current medications to identify those that are nephrotoxic or require dose adjustment after the onset of AKI 30 (100)
Avoid diuretics in the absence of volume overload after the onset of AKI 30 (100)
Recommendations for Prevention of Contrast-induced AKI:
Obtain a serum creatinine before a contrast imaging procedure 27 (90)
Use isotonic crystalloids for prevention in patients at high risk of CI-AKI 30 (100)
Use the lowest possible dose of iso-osmolar or low-osmolar iodinated contrast media in patients at high risk of CI-AKI 30 (100)
Withhold NSAIDs and diuretics before contrast administration 27 (90)
Use an imaging test that doesn’t require iodinated contrast administration in patients with AKI 28 (93)
Criteria for Nephrologist Consultation:
An unclear etiology or cause other than pre-renal or acute tubular necrosis is suspected 30 (100)
Hyperkalemia refractory to medical therapy 29 (97)
AKI that is unresponsive to treatment or worsening 28 (93)
Respiratory compromise due to volume overload in anuric patients 28 (93)
Severe AKI (i.e., KDIGO Stage 3, 3-fold increase in serum creatinine or increase in Scr > 350 μmol/L) 26 (87)
Signs or symptoms of uremia 29 (97)
A patient that may require renal replacement therapy 27 (90)
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Table 2 Process of care quality indicators identified as having a high degree of validity in the prevention,
identification, and management of acute kidney injury (AKI) after major surgery* (Continued)
Criteria for Critical Care Consultation
AKI with hemodynamic instability not responding to fluid resuscitation 30 (100)
Need for renal replacement therapy in hemodynamically unstable patient 28 (93)
Need for intubation or ventilatory support 30 (100)
Need for vasopressors or inotropes 30 (100)
*All indicators listed in this table achieved high scores for validity based on a mean score >6 on a 7-point Likert scale.
†The number (%) of panelists who scored each indicator ≥ 6 is shown in the column on the right, with the 16 high consensus indicators, for which no panelists
assigned a score <6, highlighted in bold.
‡Applicable to all patients since hydroxyl-ethyl starches shown to increase the risk of AKI and renal replacement therapy in all populations (Mutter TC, Ruth CA,
Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013 Jul 23;7).
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of care, or to evaluate changes in process of care with
knowledge translation interventions including audit and
feedback or organizational interventions. These indicators
could also be targeted by formal educational interventions
or employed as teaching tools for medical trainees.
Our study has a number of strengths. First, the modified
Delphi procedure allows for anonymity of responses from
panelists, which may provide a more accurate account of
their beliefs surrounding best practices by reducing social
desirability bias [28]. This approach minimized the risk of
a dominant panelist unduly influencing the panel that can
be observed in a less structured setting, such as a focus
group, and allowed each panelist to present their opinions
with equal weighting, regardless of seniority [29,30].
Second, this Delphi process was conducted via the
Internet allowing inclusion of panelists from multiple
locations across Alberta to participate. Third, the process
allowed participants to re-evaluate their beliefs after re-
ceiving feedback on responses from other panelists in the
third round. Finally, as candidate indicators were based on
published and unpublished literature as well as the opin-
ions of panelists, our results incorporated different forms
of evidence to develop a broad range of process indicators.
There are also limitations to our study. First, all panel-
ists were from Alberta Canada, thus external validity may
be limited in other health care settings where practices
differ. However, the challenges of prevention, early identi-
fication and management of AKI following major surgery
are likely to be similar across different health care settings.
Second, we focused on medical care for AKI, and did not
include anesthesiologists who may have provided different
perspectives on intraoperative processes of care. Third, we
focused on processes of care that could be generalized to
all patients after major surgery, rather than features of
specific types of surgical procedures themselves (e.g.
on-pump versus off-pump cardiac surgery) that may alter
the risk of AKI. Finally, this modified Delphi process
focused on obtaining input on the face validity but not thefeasibility of measuring these process indicators for AKI
[23]. Future work is required to determine the practicality
and accuracy of measuring these variables in clinical
settings.Conclusion
In summary, we used an iterative stepwise approach to
obtain expert clinician opinions on indicators of process
of care for prevention, identification, and management of
perioperative AKI. These indicators can be used to design
and evaluate initiatives to improve the care of patients
with or at risk of AKI after surgery.Appendix 1 All process of care indicators
Prevention and Early Identification of AKI after major
surgery (12)
Obtain a serum creatinine before surgery
Use isotonic crystalloids to expand intravascular volume
during surgery
Monitor serum creatinine daily to identify AKI after
surgery
Monitor urine output daily to identify AKI after surgery
Monitor fluid balance daily after surgery
In the absence of volume overload, provide maintenance
IV fluids after surgery
Administer aminoglycosides using single daily dosing
in patients at risk of AKI
Discontinue non-steroidal anti-inflammatory drugs prior
to surgery
Avoid repeated exposure to iodinated contrast after
surgery
Monitor serum creatinine after prescribing a nephrotoxic
drug
Avoid hydroxy-ethyl starch for volume expansion in
patients with reduced kidney function
Flag patients at high risk of perioperative acute kidney
injury in the medical record
Obtain a urinalysis before surgery
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Discontinue ACE inhibitors/angiotensin receptor clockers
(ARBs) prior to surgery
Discontinue diuretics prior to surgery
Discontinue calcineurin-inhibitors prior to surgery
Monitor serum urea daily to identify volume depletion
prior to a rise in serum creatinine
Monitor intra-abdominal pressure after complex intra-
abdominal surgery
Early Management of AKI After major surgery (12)
Perform a urinalysis for investigation of the cause of AKI
Determine the severity of AKI by monitoring serum
creatinine daily after the onset of AKI
Determine the severity of AKI by monitoring urine
output daily after the onset of AKI
Monitor fluid balance daily after the onset of AKI
Monitor for acid–base disturbances after the onset of AKI
Monitor for hyperkalemia after the onset of AKI
Provide intravenous crystalloids to optimize hemodynamic
status and restore effective circulating volume and
blood pressure in patients with AKI and signs of vol-
ume depletion
Avoid non-steroidal anti-inflammatory drugs after the
onset of AKI
Avoid aminoglycosides after the onset of AKI unless
no other antibiotics are available
Provide vasopressors/inotropes to patients with AKI
and vasomotor shock that does not respond to IV fluids
Review current medications to identify those that are
nephrotoxic or require dose adjustment after the onset
of AKI
Avoid diuretics in the absence of volume overload
after the onset of AKI
Avoid angiotensin converting enzyme inhibotors/
angiotensin receptor blocking drugs after the onset of
AKI
Weigh patients daily after the onset of AKI
Recommendations for Prevention of Contrast-induced
AKI (5)
Obtain a serum creatinine before a contrast imaging
procedure
Use isotonic crystalloids for prevention in patients at
high risk of CI-AKI
Use the lowest possible dose of iso-osmolar or low-
osmolar iodinated contrast media in patients at high risk
of CI-AKI
Withhold NSAIDs and diuretics before contrast
administration
Use an imaging test that doesn’t require iodinated con-
trast administration in patients with AKI
Obtain a urinalysis before a contrast imaging procedure
Administer acetylcysteine to patients at high risk of CI-AKICriteria for Nephrologist Consultation (7)
An unclear etiology or cause other than pre-renal or
acute tubular necrosis is suspected
Hyperkalemia refractory to medical therapy
AKI that is unresponsive to treatment or worsening
Respiratory compromise due to volume overload in
anuric patients
Severe AKI (i.e., KDIGO Stage 3, 3-fold increase in
serum creatinine or increase in Scr>350 μmol/L)
Signs or symptoms of uremia
A patient that may require renal replacement therapy
Hyperkalemia
Metabolic acidosis
All cases of AKI (i.e., always consult Nephrology)
Pre-existing kidney disease
Volume overload
Anuria not reversing with intravenous fluid
Criteria for Critical Care Consultation (4)
AKI with hemodynamic instability not responding to
fluid resuscitation
Need for renal replacement therapy in hemodynamically
unstable patient
Need for intubation or ventilatory support
Need for vasopressors or inotropes
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